ENTITY

IO Biotech Inc (IOBT US)

1
Analysis
Health CareUnited States
IO Biotech, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing novel, immune-modulating cancer therapies based on our T-win technology platform to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech serves customers in Denmark.
more
Company Event07 Mar 2026 05:00 • Upcoming
Add To Calendar
Company Event04 Dec 2025 04:00 • Latest
Company Event02 Dec 2025 20:55
Company Event19 Nov 2025 05:00 • Upcoming
Add To Calendar
Company Event18 Nov 2025 23:00
x